Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial

BACKGROUND: This study is aimed at investigating whether dapagliflozin adjunct to insulin therapy further improves glycemic control compared to insulin therapy alone in patients with newly diagnosed type 2 diabetes (T2D). METHODS: This single-centre, randomized, controlled, open-labeled trial recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lan-lan, Zhang, Peng, Liu, Bing-li, Yan, Reng-na, Ye, Lei, Ma, Jian-hua, Li, Feng-fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419509/
https://www.ncbi.nlm.nih.gov/pubmed/34497852
http://dx.doi.org/10.1155/2021/6618257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419509/
https://www.ncbi.nlm.nih.gov/pubmed/34497852
http://dx.doi.org/10.1155/2021/6618257

Ejemplares similares